IL18 and breast carcinoma: By triggering immune cells and immune cytokines, human mesenchymal stem cells from the umbilical cord (hUMSCs)-expressing IL-18 have been shown to suppress the growth, invasion, and metastasis of breast cancer cells in vitro, lowering the proliferation index of the marker Ki-67, and halting tumor progression (143).